Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

Job cuts at Allergan and Transgene

3 July 2015 Business

Allergan is shedding 300 staff at former Actavis site in Iceland, while Transgene is closing its French manufacturing plant with loss of 120 jobs

Fracking prohibited in New York state and Lancashire

2 July 2015 Business

Local US and UK rulings prohibit shale oil drilling and exploration

What's in a name?

30 June 2015 Editorial

Business leader: Why do companies attach abstract values to their names?

Collaboration, not competition

29 June 2015 Research

Organic chemist E J Corey talks to Phillip Broadwith about awards, ambition and academic freedom

Missing the target

23 June 2015 In the Pipeline

There are plenty of things that small molecule drugs can’t touch, says Derek Lowe, and it’s not for want of trying

Opko deepens diagnostics with $1.5bn lab buyout

9 June 2015 Business

Taking over clinical diagnostics service provider BioReference Laboratories gives Opko a bigger avenue to distribute and market its diagnostic tests

Vertex nabs rights to cystic fibrosis molecules

9 June 2015 Business

Deal with Parion, worth up to $1bn, gives firm worldwide rights to investigational treatments that complement Vertex’s existing cystic fibrosis drugs

Takeda to consolidate vaccines business in Boston

4 June 2015 Business

Firm will close three recently-acquired US sites and shift operations to the growing pharmaceutical hub in Massachusetts

OM Group to be sold and split

2 June 2015 Business

Apollo Global Management will buy the firm for $1bn, then sell electronic materials business to Platform Specialty Products

Teva fined $1.2bn in pay-for-delay case

1 June 2015 Business

Company illegally blocked generic competition of sleep disorder drug, and settlement terms tighten up rules on anticompetitive behaviour

Achillion partners with Janssen to boost hepatitis C pipeline

29 May 2015 Business

Development deal worth up to $1.1bn includes three investigational drugs aiming to extend treatment options in fast-moving market

Label laundry

27 May 2015 Editorial

Business leader: It's been an interesting month in the world of off-label pharmaceuticals

Actavis plan to thwart generics blocked

27 May 2015 Business

Company prevented from withdrawing original formulation of Alzheimer’s drug to force patients onto extended release version and extend patent exclusivity

Endo to buy Par as generics consolidation continues

26 May 2015 Business

$8bn deal follows trend as drugmakers aim for economies of scale

GSK commits to HIV research

19 May 2015 Business

Firm will partner with US university and cancels plan to sell its share of ViiV Healthcare joint venture

Dupont overcomes investor challenge

15 May 2015 Business

Shareholders decline to elect activist board nominees in a show of support for the current management’s strategy

Alexion to buy Synageva for rare disease drugs

12 May 2015 Business

$8.4bn deal gives firm access to enzyme drug currently under review with US and EU regulators

Zoetis to sell or close 10 plants in cost-cutting drive

11 May 2015 Business

Animal health firm will slash product portfolio in a bid to save $300m annually

Takeda offers $2.4bn to settle diabetes litigation

11 May 2015 Business

Aims to settle multiple outstanding lawsuits relating to Actos (pioglitazone) and bladder cancer

Kolon and Dupont settle trade secrets case

8 May 2015 Business

Korean firm admits stealing Kevlar technology and will pay $360m in fines and restitution

Empowering employee ideas

28 April 2015 Editorial

Business leader: The dusty comment box in the canteen needs an overhaul

Daiichi Sankyo steps out after Sun-Ranbaxy merger

22 April 2015 Business

Ranbaxy’s Japanese owner has sold off its stake in the merged company, but will retain its business partnership

Environmental research goes private

1 April 2015 Business

Exclusive interview with Fera chief Hilary Aldridge as the UK's Food and Environment Research Agency becomes majority-owned by Capita

Valeant heads off Endo bid for Salix

25 March 2015 Business

Bid raised to $15.8 billion in cash after rival offer from Irish firm

Measuring up

24 March 2015 Editorial

Business leader: How should we assess companies’ performance?